A medullary thyroid cancer (MTC)/multiple endocrine neoplasia syndrome was suspected in a patient having an metaiodobenzylguanidine (MIBG) scan while she was being investigated for pheochromocytoma. After surgery, this was confirmed histologically. Although MIBG scanning cannot be used as a screening tool for MTC because of its poor sensitivity for detection of MTC, this case report highlights that one should always scrutinize the thyroid gland while interpreting MIBG scans.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RLU.0b013e31816a7a4d | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!